Natera, Inc.(NTRA)

Description: Natera, Inc., a genetic testing company, develops and commercializes non-invasive methods for analyzing deoxyribonucleic acid (DNA) in the United States and Europe. The company primarily offers Panorama, a non-invasive prenatal test for fetal chromosomal abnormalities; Horizon test; and pre-implantation genetic screening and pre-implantation genetic diagnosis tests under the Spectrum brand to analyze chromosomal anomalies or inherited genetic conditions during an in vitro fertilization. It also provides products of conception testing under the Anora brand to analyze fetal chromosomes to understand the cause of miscarriage; non-invasive paternity testing products to determine paternity by analyzing the fragments of fetal DNA in a pregnant mother's blood and a blood sample from the alleged father; and high throughput carrier screening to determine the risk of passing severe genetic diseases on to offspring. Natera sells its tests directly and partner with other clinical laboratories to distribute its tests. The company was formerly known as Gene Security Network, Inc. and changed its name to Natera, Inc. in 2012. Natera, Inc. was founded in 2003 and is headquartered in San Carlos, California.

---

Keywords: Medicine Clinical Medicine Acid Medical Test Medical Genetics In Vitro Lab Testing Applied Genetics DNA Genetic Diseases Genetic Testing In Vitro Fertilization Prenatal Testing Natera Cell Free Fetal Dna DNA Paternity Testing Severe Genetic Diseases

---

Home Page: www.natera.com

NTRA Technical Analysis

13011 McCallen Pass Building A
San Carlos, CA 78753
United States
Phone: 650 249 9090

---

Officers

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)